Drug intelligence / Profile preview

Mesogen RPE Cell Patch

Development stage
Preclinical
Lead developer
Mesogen
Modality
Tissue Cells → Other Cell Types → Cell Therapies, Stem Cell Therapies → Cell Therapies
Administration
Ophthalmic
01

Overview

Mesogen is developing an autologous engineered Retinal Pigment Epithelium (RPE) cell patch for the treatment of age-related macular degeneration (AMD). The therapy involves isolating stem cells from a patient's bone marrow, which are then expanded and differentiated into RPE cells using a proprietary process. These cells are seeded onto an electrospun poly(lactic-co-glycolic acid) (PLGA) scaffold that is designed to dissolve over approximately three months. The completed tissue-engineered patch is surgically transplanted into the subretinal space to replace damaged RPE and restore or maintain retinal function. Because the therapy utilizes the patient's own cells, it is designed to avoid the need for long-term systemic immunosuppression and carries no risk of teratoma formation.

Other names
Autologous engineered Retinal Pigment Epithelium (RPE) cell patchesRPE patch

Beyond the preview

Go deeper on Mesogen RPE Cell Patch.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mesogen RPE Cell Patch.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call